Finance

Lists
Why is AARD down ၇.၇၄%?
Dive Deeper
AARD:NASDAQ
Aardvark Therapeutics Inc
၀.၉၂ US$
-၇.၇၄%
(-၀.၀၇၇) 1D
နို ၂၀, GMT-၅ ၁၆:၀၀:၀၂  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for AARD...
Open
၁.၀၀ US$
High
၁.၀၆ US$
Low
၀.၉၀ US$
Mkt. cap
၂.၀၂ ကုဋေ
Avg. vol.
၁.၂၂ သန်း
Volume
၂.၄၁ သိန်း
52-wk high
၁၆.၆၀ US$
52-wk low
၀.၉၀ US$
EPS
-၃.၃၃ US$
Shares outstanding
၂.၁၉ ကုဋေ
No. of employees
၂၇
Open
၁.၀၀ US$
High
၁.၀၆ US$
Low
၀.၉၀ US$
Mkt. cap
၂.၀၂ ကုဋေ
Avg. vol.
၁.၂၂ သန်း
Volume
၂.၄၁ သိန်း
52-wk high
၁၆.၆၀ US$
52-wk low
၀.၉၀ US$
EPS
-၃.၃၃ US$
Shares outstanding
၂.၁၉ ကုဋေ
No. of employees
၂၇
News stories
From web sources and news partners
TradingView
TradingView
·
ပြီးခဲ့သည့် ၂ ရက်
Aardvark Therapeutics, Inc. Stock 12‑Month Price Target Cut to $3.5, Implies 250% Upside
About Aardvark Therapeutics Inc
CEO-
Employees၂၇
Founded၂၀၁၇
Headquarters-
SectorHealth Care
Industry-
Analyst ratings
Based on 7 analysts giving stock ratings to AARD in the past 3 months
Sell
Buy
0
Hold
5
Sell
2
12-month forecast
Based on 7 Wall Street analysts offering 12 month price targets for AARD in the last 3 months.
Highest
Current ၀.၉၂ US$
၃.၀၀ US$ (+၂၂၅.၁၇%)
Average
၂.၂၀ US$ (+၁၃၈.၄၆%)
Lowest
၁.၅၀ US$ (+၆၂.၅၈%)
Analyst
Recommendation
Action
Price target
Projected
Date
James Condulis
Stifel Nicolaus
Hold
Maintained
၂.၀၀ US$
+၁၁၆.၈%
11/17/2026
Michael Ulz
Morgan Stanley
Sell
Maintained
၃.၀၀ US$
+၂၂၅.၂%
11/13/2026
Brian Abrahams
RBC Capital
Hold
Maintained
၂.၅၀ US$
+၁၇၁%
11/13/2026
Christopher Raymond
Raymond James
Hold
Downgraded
-
-
11/04/2026
Leland Gershell
Oppenheimer
Hold
Downgraded
-
-
10/26/2026
Ram Selvaraju
H.C. Wainwright
Hold
Maintained
၂.၀၀ US$
+၁၁၆.၈%
10/26/2026
Tazeen Ahmad
Bank of America Securities
Sell
Reiterated
၁.၅၀ US$
+၆၂.၆%
10/23/2026
Jeet Mukherjee
BTIG
Hold
Maintained
-
-
08/12/2026
Andy Hsieh
William Blair
Buy
Reiterated
-
-
08/12/2026
William Wood
B. Riley Securities
Buy
Maintained
၇.၀၀ US$
+၆၅၈.၇%
05/15/2026
Tim Anderson
Bank of America Securities
Buy
Reiterated
၁၈.၀၀ US$
+၁,၈၅၁%
05/08/2026
Joshua Schimmer
Cantor Fitzgerald
Buy
Maintained
၄၅.၀၀ US$
+၄,၇၇၇.၅%
03/02/2026
Last report
၂၀၂၆ နို ၁၃
Fiscal period
Q3 2026
-၀.၈၈ US$ / -၀.၇၇ US$
-၁၄.၂၉%miss
Revenue / Est. (USD)
- / ၀.၀၀
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
၂၀၂၅ ဒီ
၂၀၂၆ မတ်
၂၀၂၆ ဇွန်
၂၀၂၆ စက်
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
၁.၄၃ ကုဋေ
၁.၆၆ ကုဋေ
၁.၀၅ ကုဋေ
၁.၅၇ ကုဋေ
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
၄.၄၀ သန်း
၅.၉၀ သန်း
၄.၆၃ သန်း
၄.၀၅ သန်း
Operating expense
၁.၈၇ ကုဋေ
၂.၂၅ ကုဋေ
၁.၅၁ ကုဋေ
၁.၉၇ ကုဋေ
Total operating expenses
၁.၈၇ ကုဋေ
၂.၂၅ ကုဋေ
၁.၅၁ ကုဋေ
၁.၉၇ ကုဋေ
Operating income
-၁.၈၇ ကုဋေ
-၂.၂၅ ကုဋေ
-၁.၅၁ ကုဋေ
-၁.၉၇ ကုဋေ
Other non operating income
-
-
-
-
EBT including unusual items
-၁.၇၆ ကုဋေ
-၂.၁၆ ကုဋေ
-၁.၄၄ ကုဋေ
-၁.၉၂ ကုဋေ
EBT excluding unusual items
-၁.၇၆ ကုဋေ
-၂.၁၆ ကုဋေ
-၁.၄၄ ကုဋေ
-၁.၉၂ ကုဋေ
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-၁.၇၆ ကုဋေ
-၂.၁၆ ကုဋေ
-၁.၄၄ ကုဋေ
-၁.၉၂ ကုဋေ
Net profit margin
-
-
-
-
Earnings per share
-၀.၈၁
-၀.၉၉
-၀.၆၆
-၀.၈၈
Interest and investment income
၁.၁၂ သန်း
၈.၈၉ သိန်း
၆.၉၅ သိန်း
၅.၃၉ သိန်း
Interest expense
-
-
-
-
Net interest expenses
၁.၁၂ သန်း
၈.၈၉ သိန်း
၆.၉၅ သိန်း
၅.၃၉ သိန်း
Depreciation and amortization charges
-
-
-
-
EBITDA
-၁.၈၇ ကုဋေ
-၂.၂၅ ကုဋေ
-၁.၅၁ ကုဋေ
-၁.၉၇ ကုဋေ
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
Google အက်ပ်များ